Chaves Míriam Martins, Costa Daniela Caldeira, Pereira Cristina Costa Telhado, Andrade Thiago Rabelo, Horta Bernardo Coelho, Nogueira-Machado José Augusto
Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Gerontology. 2007;53(4):228-33. doi: 10.1159/000100960. Epub 2007 Mar 20.
It is generally agreed that elderly subjects undergo progressive deterioration of their immune responsiveness, which leads to an increased susceptibility to autoimmune processes, neoplasm and inflammation. Thus there is a general consensus that regulation of inflammation results from a balance between pro-inflammatory and anti-inflammatory pathways.
The present study aimed to investigate the possible alterations of cyclic AMP/protein kinase A (cAMP/PKA) and p38 mitogen-activated protein kinase (p38 MAPK) pathway signaling (reactive oxygen species (ROS) generation) and inositol 1,4,5-triphosphate (InsP3) production by neutrophils during the aging process.
Age-induced ROS generation and InsP3 production were studied in healthy subjects ranging in age from 20 to 80 years. The subjects were divided into six age groups: (I) 20-29, (II) 30-39, (III) 40-49, (IV) 50-59, (V) 60-69, and (VI) 70-80 years old. The effect of cAMP, H89 (inhibitor PKA), and PD169316 (inhibitor p38 MAPK) on ROS production was quantified in a luminol-dependent chemiluminescence assay (relative light units/min) and by InsP3 release (cpm).
Our results demonstrated a lack of dibutyryl cAMP inhibitory effects on ROS generation and InsP3 production by granulocytes from PKA-dependent 50-year-olds. However, the inhibitory effect of cAMP is restored in neutrophils after the age of 50 years when p38 MAPK signaling is inhibited.
The present study may be important towards a better understanding of the high susceptibility to infections and age-related inflammatory and deregulation diseases. The alteration of cAMP/PKA and p38 MAPK signaling pathways enhances the inflammatory process.
人们普遍认为,老年受试者的免疫反应性会逐渐衰退,这导致他们对自身免疫过程、肿瘤和炎症的易感性增加。因此,人们普遍认为炎症的调节源于促炎和抗炎途径之间的平衡。
本研究旨在调查衰老过程中中性粒细胞的环磷酸腺苷/蛋白激酶A(cAMP/PKA)和p38丝裂原活化蛋白激酶(p38 MAPK)信号通路信号(活性氧(ROS)生成)以及肌醇1,4,5-三磷酸(InsP3)生成可能发生的变化。
对年龄在20至80岁的健康受试者进行了衰老诱导的ROS生成和InsP3生成研究。受试者被分为六个年龄组:(I)20 - 29岁,(II)30 - 39岁,(III)40 - 49岁,(IV)50 - 59岁,(V)60 - 69岁,以及(VI)70 - 80岁。通过鲁米诺依赖性化学发光测定法(相对光单位/分钟)和InsP3释放(每分钟计数)对cAMP、H89(PKA抑制剂)和PD169316(p38 MAPK抑制剂)对ROS生成的影响进行了定量。
我们的结果表明,二丁酰cAMP对来自依赖PKA的50岁受试者的粒细胞的ROS生成和InsP3生成缺乏抑制作用。然而,当p38 MAPK信号通路被抑制时,50岁以后中性粒细胞中cAMP的抑制作用得以恢复。
本研究对于更好地理解对感染以及与年龄相关的炎症和失调疾病的高易感性可能具有重要意义。cAMP/PKA和p38 MAPK信号通路的改变会增强炎症过程。